|Bid||24.00 x 1100|
|Ask||24.08 x 1000|
|Day's Range||23.95 - 26.01|
|52 Week Range||5.30 - 27.24|
|Beta (5Y Monthly)||1.54|
|PE Ratio (TTM)||N/A|
|Earnings Date||Mar 08, 2021 - Mar 12, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||37.00|
Protagonist Therapeutics, Inc. (NASDAQ: PTGX) today announced that Dinesh V. Patel, Ph.D., President and Chief Executive Officer, will participate in a fireside chat at SVB Leerink Virtual 10th Annual Global Healthcare Conference taking place February 22 to February 26, 2021.
Protagonist Therapeutics, Inc. (Nasdaq:PTGX) today reported that on January 29, 2021, it issued an inducement award to Paula O'Connor, M.D., the Company's recently hired Senior Vice President, Clinical Development, in accordance with the terms of Dr. O'Connor's employment offer letter. The award was granted under the Protagonist Therapeutics Amended and Restated Inducement Plan, which was adopted May 29, 2018, and amended February 18, 2020.
It is not uncommon to see companies perform well in the years after insiders buy shares. Unfortunately, there are also...